ORGO FY 2020 Earnings — Organogenesis Holdings Inc. Revenue & Financial Results | Market Cap Arena

ORGOOrganogenesis Holdings Inc.

$355M

FY 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$338M+29.6% YoY

Gross Profit

$251M74.2% margin

Operating Income

$27M7.9% margin

Net Income

$17M5.1% margin

EPS (Diluted)

$0.15

Cash Flow

Operating Cash Flow

$5M

Free Cash Flow

-$12M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$290M

Total Liabilities

$148M

Stockholders' Equity

$142M

Cash & Equivalents

$84M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$338M	$261M	+29.6%
Gross Profit	$251M	$185M	+35.6%
Operating Income	$27M	-$30M	+189.4%
Net Income	$17M	-$39M	+144.5%